Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Three different human endometrial cancer cell lines known to have wild type PTEN (HEC 1-A) or a mutated inactive PTEN protein (RL 95-2 and Ishikawa) were used for these studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP843039.RAcyJNdf0pkq_xZOmtr8uTlqbhVbMW76DO9jfEcCJ5YpE130_assertion description "[Three different human endometrial cancer cell lines known to have wild type PTEN (HEC 1-A) or a mutated inactive PTEN protein (RL 95-2 and Ishikawa) were used for these studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843039.RAcyJNdf0pkq_xZOmtr8uTlqbhVbMW76DO9jfEcCJ5YpE130_provenance.
• assertion description "[Three different human endometrial cancer cell lines known to have wild type PTEN (HEC 1-A) or a mutated inactive PTEN protein (RL 95-2 and Ishikawa) were used for these studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Three different human endometrial cancer cell lines known to have wild type PTEN (HEC 1-A) or a mutated inactive PTEN protein (RL 95-2 and Ishikawa) were used for these studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Three different human endometrial cancer cell lines known to have wild type PTEN (HEC 1-A) or a mutated inactive PTEN protein (RL 95-2 and Ishikawa) were used for these studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Three different human endometrial cancer cell lines known to have wild type PTEN (HEC 1-A) or a mutated inactive PTEN protein (RL 95-2 and Ishikawa) were used for these studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Three different human endometrial cancer cell lines known to have wild type PTEN (HEC 1-A) or a mutated inactive PTEN protein (RL 95-2 and Ishikawa) were used for these studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Three different human endometrial cancer cell lines known to have wild type PTEN (HEC 1-A) or a mutated inactive PTEN protein (RL 95-2 and Ishikawa) were used for these studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP435349.RAABx9k9XBIeJDNzcPEPZKzbOvA2nuusFQWxcdjYQvMuw130_assertion description "[Three different human endometrial cancer cell lines known to have wild type PTEN (HEC 1-A) or a mutated inactive PTEN protein (RL 95-2 and Ishikawa) were used for these studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435349.RAABx9k9XBIeJDNzcPEPZKzbOvA2nuusFQWxcdjYQvMuw130_provenance.
• NP435355.RAhj_CGocUI2TReOigAe-_d7atgu9o11qfor4hP-HnMbM130_assertion description "[Three different human endometrial cancer cell lines known to have wild type PTEN (HEC 1-A) or a mutated inactive PTEN protein (RL 95-2 and Ishikawa) were used for these studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435355.RAhj_CGocUI2TReOigAe-_d7atgu9o11qfor4hP-HnMbM130_provenance.
• NP435357.RAjJtQL1OdD1vObUt0oQ4uuWYifxOUYpJ78rrQ5WxOmZI130_assertion description "[Three different human endometrial cancer cell lines known to have wild type PTEN (HEC 1-A) or a mutated inactive PTEN protein (RL 95-2 and Ishikawa) were used for these studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435357.RAjJtQL1OdD1vObUt0oQ4uuWYifxOUYpJ78rrQ5WxOmZI130_provenance.
• NP435353.RALZ5VTjehORSGtMqx6pKy49ay1C30mEgIRkT_vF-reJU130_assertion description "[Three different human endometrial cancer cell lines known to have wild type PTEN (HEC 1-A) or a mutated inactive PTEN protein (RL 95-2 and Ishikawa) were used for these studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435353.RALZ5VTjehORSGtMqx6pKy49ay1C30mEgIRkT_vF-reJU130_provenance.
• NP435346.RAzmE3ch6B14T4rIBVgNcC2eQ0vLmTHUvHzteLVFf2j88130_assertion description "[Three different human endometrial cancer cell lines known to have wild type PTEN (HEC 1-A) or a mutated inactive PTEN protein (RL 95-2 and Ishikawa) were used for these studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435346.RAzmE3ch6B14T4rIBVgNcC2eQ0vLmTHUvHzteLVFf2j88130_provenance.
• NP435348.RAwqcPpvE6DFyA9HqgwlTZRqmB4I1ufu5NFFwsirE1M5A130_assertion description "[Three different human endometrial cancer cell lines known to have wild type PTEN (HEC 1-A) or a mutated inactive PTEN protein (RL 95-2 and Ishikawa) were used for these studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435348.RAwqcPpvE6DFyA9HqgwlTZRqmB4I1ufu5NFFwsirE1M5A130_provenance.
• NP842971.RA1I3xN4F7SJqTXQxeUGK60JmWDzauWNGie8jihu0dYWM130_assertion description "[Three different human endometrial cancer cell lines known to have wild type PTEN (HEC 1-A) or a mutated inactive PTEN protein (RL 95-2 and Ishikawa) were used for these studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842971.RA1I3xN4F7SJqTXQxeUGK60JmWDzauWNGie8jihu0dYWM130_provenance.